Cipher Pharmaceuticals Inc. Navigation
  • About Us
    • Overview
    • Leadership
    • Board of Directors
  • Products
    • Overview
    • Dermatology
    • Hospital Acute Care
    • Gastrointestinal
    • Out-Licensed Products
  • Pipeline
  • Business Development
  • Investors
  • Careers
  • Contact
  • | FR
  • About Us
    • Overview
    • Leadership
    • Board of Directors
  • Products
    • Overview
    • Dermatology
    • Hospital Acute Care
    • Gastrointestinal
    • Out-Licensed Products
  • Pipeline
  • Business Development
  • Investors
  • Careers
  • Contact
  • | FR

Cipher Pharmaceuticals

Cipher is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products

Cipher Pharmaceutical ProductsProducts
Cipher Product PipelinePipeline

RSS News

  • Cipher Pharmaceuticals Appoints New Chief Financial Officer July 2, 2020
  • Cipher Pharmaceuticals Reports First Quarter 2020 Financial Results May 8, 2020

Events

Q1 2020 Results Conference Call/Webcast
Friday, May 8, 2020

Webcast Replay

Cipher Investor Information

Investors

  • Financial Reports
  • Investor Presentation
  • Corporate Governance Documents
  • Webcasts

Legal Notices  |  Terms & Conditions  |  Privacy Policy
©2020 Cipher Pharmaceuticals Inc. All Rights Reserved.

 

.
Contact | U.S. Business